Ofatumumab Is More Efficient than Rituximab in Lysing B...

The Journal of Immunology 2013 / 01 Vol. 190; Iss. 1

Ofatumumab Is More Efficient than Rituximab in Lysing B Chronic Lymphocytic Leukemia Cells in Whole Blood and in Combination with Chemotherapy

Bologna, L., Gotti, E., Da Roit, F., Intermesoli, T., Rambaldi, A., Introna, M., Golay, J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
190
Language:
english
Journal:
The Journal of Immunology
DOI:
10.4049/jimmunol.1202645
Date:
January, 2013
File:
PDF, 1.23 MB
english, 2013
Conversion to is in progress
Conversion to is failed